Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00593918 · ClinicalTrials.gov registry record
Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 91
- Enrollment target
NCT00593918: Completed study, sponsored by University of Wisconsin, Madison.
NCT00593918 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 91 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00593918 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
Study Summary
In this project we will study the capacity for single nucleotide polymorphisms (SNP) in TLR4 gene to induce varying levels of inflammatory chemokine and cytokine production.
Primary Outcome
Interferon a2 was measured from nasal lavage samples by Luminex multiplex assay.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2003-11 |
| Est. Completion | 2008-06 |
What the finished NCT00593918 record still lists
NCT00593918 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 91 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00593918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00593918 about?
NCT00593918 is a clinical study titled "Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children". In this project we will study the capacity for single nucleotide polymorphisms (SNP) in TLR4 gene to induce varying levels of inflammatory chemokine and cytokine production.
What is the current status of trial NCT00593918?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2003-11. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00593918?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia